The homologous recombination pathway is frequently altered in advanced prostate cancer plasticity is a hallmark of cancer in general and a very important feature of advanced prostate cancer, particularly when it comes to the emergence of treatment resistance, says shen. Recent approvals of new treatments have led to improved outcomes for patients with advanced prostate cancer 1,2
However, metastatic disease remains aggressive and progression is inevitable. The drug aims to extend the effectiveness of existing prostate cancer treatments such as hormone therapy. Mckay concluded her presentation discussing emerging frontiers in metastatic prostate cancer with the following take home points
